Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Howard Hughes Holdings Inc. reported Q1 2026 financial results demonstrating a 33% increase in Master Planned Communities (MPC) earnings before taxes, driven by higher residential land sales primarily in Bridgeland, alongside steady growth in operating assets net operating income (NOI). Despite a slight decline in net income attributable to common …
Rocket Lab announced it has signed its largest launch deal to date with a confidential customer for multiple launches of its Neutron and Electron rockets, raising its total launch backlog beyond 70 missions valued at more than $2.2 billion. This multi-launch agreement expands Rocket Lab's commercial and government space launch services, demonstrati…
Jeffrey Zerillo, the Senior Vice President of Operations at Prestige Consumer Healthcare Inc. (NASDAQ:PBH), has executed multiple transactions involving the company's common stock. According to recent SEC filings, these disposals occurred on May 5, 2026. The sales come at a time when the consumer healthcare company is undergoing significant structu…
Gilead Sciences reported first-quarter results that beat expectations on both earnings and revenue, and boosted its 2026 sales projection, led by stronger-than-expected demand for its HIV prevention drug Yeztugo. However, the company revised its full-year profit outlook to an adjusted loss because of acquisition-related charges and financing costs …
Jade Biosciences announced their first quarter 2026 financial results and updated on clinical pipeline milestones, including upcoming Phase 1 and Phase 2 trials for their lead program JADE101 targeting IgA nephropathy, and initiation of trials for JADE201 and JADE301. The company holds $311 million in cash, enough to fund operations into mid-2028, …
Sprout Social, Inc. announced its Q1 2026 financial results, showing 11% year-over-year revenue growth to $121.5 million and a 21% increase in subscription revenue contribution from customers with ARR $30K or more. The company reported $24.7 million non-GAAP free cash flow and improved profitability. They also initiated their first-ever $50 million…
GSI Technology, Inc. announced its financial results for the fourth quarter and fiscal year ended March 31, 2026, highlighting a 22% revenue increase driven by higher SRAM sales and expanded gross margins. The company completed software milestones supporting the upcoming demonstration of its Gemini-II powered drone and secured $2 million in new U.S…
NextCure announced a business update and financial results for Q1 2026, highlighting the FDA's Fast Track designation for its SIM0505 antibody-drug conjugate targeting platinum-resistant ovarian cancer. The company plans to present Phase 1 data at ASCO 2026 and expand clinical trial sites in North America and Europe. Financially, NextCure reported …
Myriad Genetics announced that its management will participate in the BofA Securities 2026 Health Care Conference and Goldman Sachs 47th Annual Global Healthcare Conference. These events provide platforms for investor engagement and sharing strategic insights about the company's molecular diagnostic testing and precision medicine initiatives.
ImmuCell Corporation, a Nasdaq-listed animal health biologics company specializing in calf health products, announced it will report its unaudited financial results for the quarter ended March 31, 2026, on May 14 after market close. The company plans a conference call on May 15 to discuss the results and expects no changes to previously announced p…
Fidus Investment Corporation announced its Q1 2026 financial results highlighted by a 35.2% increase in net investment income to $24.6 million ($0.65 per share), a 30.2% rise in total investment income, and increased fee and interest income. The company declared a total dividend of $0.62 per share for Q2 2026, including a supplemental dividend of $…
Organogenesis Holdings Inc. reported a challenging first quarter of 2026 with net revenue declining 58% year-over-year to $36.3 million, driven by a 63% decrease in Advanced Wound Care sales. The company posted a net loss of $53.2 million, significantly larger than the $18.8 million loss a year earlier. Operating expenses remained high at $106.1 mi…
Profound Medical Corp. reported a strong first quarter for 2026, showcasing 104% revenue growth year-over-year, improved operating performance, and reduced net loss. Key achievements include expansion of installed TULSA-PRO systems, positive clinical trial results affirming safety superiority, and Humana becoming the first major US insurer to cover…
ICU Medical, Inc. announced its first quarter 2026 financial results, showing GAAP revenue decline of 12% year-over-year primarily due to the strategic divestiture of the IV Solutions business. However, non-GAAP organic revenue increased by 1%, and profitability improved significantly with a GAAP net income of $30.1 million compared to a net loss i…
Nutanix, a leader in hybrid multicloud computing, has announced that it will report its financial results for the third quarter of fiscal 2026 on May 27, 2026, after U.S. markets close. The company will host a conference call and webcast to discuss its results on the same day.
Crinetics Pharmaceuticals reported robust first quarter 2026 financial results highlighted by $10.3 million in net product revenue from the commercial launch of PALSONIFY, a treatment for acromegaly. The company has expanded its prescriber base and patient enrollment forms, gained significant reimbursement coverage, and achieved regulatory approval…
Lynette Holzbaur, serving as the Senior Vice President and Corporate Controller at Organon & Co. (NASDAQ: OGN), has executed a sale of common stock totaling $353,080. The transaction, which occurred on May 6, 2026, involved the sale of 26,448.366 shares at a price point of $13.3498 per share. This move follows an update to previous filings that cor…
According to a recent SEC Form 4 filing, Lilly Endowment Inc. has reduced its position in Eli Lilly & Co. (NYSE:LLY) through the sale of 15,828 shares of common stock on May 6, 2026. The divestment, which totaled approximately $15.75 million, was conducted via multiple transactions at various price points within the $995.00 to $996.46 range. Despit…
In a recent filing, it was disclosed that Lewis C. Addison, a director at Bank of the James Financial Group Inc. (NASDAQ: BOTJ), has increased his stake in the company through a direct purchase of common stock. The transaction, which occurred on May 7, 2026, involved the acquisition of 82 shares at an individual price point of $23.175 per share. Th…
Market activity in March and April included short positions on crude, diesel and gasoline futures worth as much as $7 billion, placed across multiple exchanges minutes before a series of U.S. presidential announcements related to Iran. The scale of the trades eclipses prior reports of $2.6 billion and has led to probes and calls for regulatory scru…
SoundHound AI announced a strong first quarter with revenue rising 52% year-over-year to $44.2 million, driven by demand in automotive and IoT AI verticals. The company launched the OASYS self-learning agentic AI platform and plans to acquire LivePerson, combining voice AI with digital messaging services for a robust enterprise presence. SoundHound…
Texas Roadhouse, Inc. announced its Q1 2026 financial results, highlighting a 12.8% increase in total revenue and an 8.6% increase in net income versus the prior year. Comparable restaurant sales grew by 7.1%. The company opened six new restaurants during the quarter, including franchise locations, and invested heavily in capital expenditures and a…
Catalyst Pharmaceuticals, a U.S.-based biopharmaceutical company focused on rare diseases, has canceled its first quarter 2026 earnings conference call scheduled for May 12, following the announcement of its pending acquisition by Angelini Pharma S.p.A. The company will still release its Q1 2026 financial results on May 11 as planned.
WillScot Holdings Corporation, a provider of innovative temporary space solutions, announced a quarterly cash dividend of $0.07 per share payable on June 17, 2026, to shareholders of record as of June 3, 2026. The company serves industries including construction, manufacturing, healthcare, government, energy, and education with a comprehensive prod…
Full House Resorts reported a strong first quarter for 2026 with consolidated revenues of $74.4 million and a 14.7% increase in Adjusted EBITDA to $13.2 million. The growth was primarily driven by American Place Casino's 7.1% revenue increase and operational improvements in Colorado properties. The company is advancing construction plans for a perm…
